NCT03785509View on ClinicalTrials.gov

The Compliance of DAPT and Statins on Clinical Outcomes in Percutaneous Coronary Intervention Patients

CompletedOBSERVATIONAL

Enrollment

47,291

Participants

Timeline

Start Date

April 6, 2017

Primary Completion Date

February 6, 2018

Study Completion Date

November 30, 2018

Conditions

Platelet Aggregation InhibitorsHydroxymethylglutaryl-coa Reductase InhibitorsCompliance, MedicationAdherence, MedicationPersistence, MedicationPercutaneous Coronary Intervention

Interventions

DRUG

DAPT, Statin

Compliance of DATP, Compliance of Statin, Drug Eluting Stent, Bare Metal Stent

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

All Listed Sponsors

lead

Samsung Medical Center

OTHER

NCT03785509 - The Compliance of DAPT and Statins on Clinical Outcomes in Percutaneous Coronary Intervention Patients | Biotech Hunter | Biotech Hunter